Dr. Amy Brodtmann, director at the Eastern Cognitive Disorders Clinic and professor, joins to discuss the nuances of diagnosing frontotemporal dementia (FTD). She emphasizes the holistic approach needed in assessments, particularly regarding behavioral changes that may mask underlying conditions. The conversation delves into the complexities of distinguishing FTD from Alzheimer's disease and the potential for misdiagnosis. Brodtmann highlights the critical role of follow-up care and emerging blood biomarkers to enhance diagnostic accuracy, shedding light on an often-overlooked area in dementia care.